Hasan Tahsin Gozdas Oguz Karabay
10.4103/0253-7613.150377
Indian J Pharmacol
2015 Jan-Feb;47(1):121-2.
adverse event peginterferon alpha-2a chronic hepatitis b ototoxicity
CC BY-NC-SA
https://pubmed.ncbi.nlm.nih.gov/25821325/
Antiviral Agents / adverse effects Hearing / drug effects Hearing Loss, Sensorineural / chemically induced Hepatitis B, Chronic / drug therapy Interferon-alpha / adverse effects Polyethylene Glycols / adverse effects
Antiviral Agents / adverse effects Hearing / drug effects Hearing Loss, Sensorineural / chemically induced Hepatitis B, Chronic / drug therapy Interferon-alpha / adverse effects Polyethylene Glycols / adverse effects Case Reports Adult Audiometry Female Hearing Loss, Sensorineural / diagnosis Hearing Loss, Sensorineural / physiopathology Hepatitis B, Chronic / diagnosis Humans Recombinant Proteins / adverse effects Risk Factors Antiviral Agents Interferon-alpha Recombinant Proteins Polyethylene Glycols peginterferon alfa-2a
PMC4375807
25821325
Reversible bilateral ototoxicity in a patient with chronic hepatitis B during peginterferon alpha-2a treatment
2015